AI assistant
GILEAD SCIENCES, INC. — Director's Dealing 2014
Jul 3, 2014
29828_dirs_2014-07-03_0d624582-d63b-483f-88db-bd2a4adc8878.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2014-07-01
Reporting Person: Alton Gregg H (EVP, Corp & Med Affairs)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-07-01 | Common Stock | M | 29367 | $23.60 | Acquired | 158061 | Direct |
| 2014-07-01 | Common Stock | M | 1633 | $23.755 | Acquired | 159694 | Direct |
| 2014-07-01 | Common Stock | S | 22800 | $83.7584 | Disposed | 136894 | Direct |
| 2014-07-01 | Common Stock | S | 7400 | $84.9693 | Disposed | 129494 | Direct |
| 2014-07-01 | Common Stock | S | 800 | $85.3727 | Disposed | 128694 | Direct |
| 2014-07-01 | Common Stock | S | 700 | $83.9382 | Disposed | 127994 | Direct |
| 2014-07-01 | Common Stock | S | 1300 | $85.0435 | Disposed | 126694 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-07-01 | Non-Qualified Stock Option (right to buy) | $23.60 | M | 29367 | Disposed | 2019-01-21 | Common Stock (29367) | Direct |
| 2014-07-01 | Non-Qualified Stock Option (right to buy) | $23.755 | M | 1633 | Disposed | 2020-01-28 | Common Stock (1633) | Direct |
Footnotes
F1: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
F2: The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested.
F3: Sale prices reported for the transactions reported here range from $83.32 to $84.3120. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
F4: Sale prices reported for the transactions reported here range from $84.33 to $85.31. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
F5: Sale prices reported for the transactions reported here range from $85.3458 to $85.41. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
F6: Sale prices reported for the transactions reported here range from $83.48 to $84.41. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
F7: Sale prices reported for the transactions reported here range from $84.69 to $85.40. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.